Page 353 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPtEr 22 Phagocyte Deficiencies 333

18. Roos D, Meischl C, de Boer M, et al. Genetic analysis of patients with 33. Feld JJ, Hussain N, Wright EC, et al. Hepatic involvement and portal
leukocyte adhesion deficiency: genomic sequencing reveals otherwise hypertension predict mortality in chronic granulomatous disease.
undetectable mutations. Exp Hematol 2002;30:252–61. Gastroenterology 2008;134:1917–26.
18a. Moutsopoulos NM, Zerbe CS, Wild T, et al. Interleukin-12 and 34. Segal BH, DeCarlo ES, Kwon-Chung KJ, et al. Aspergillus nidulans
interleukin-23 blockade in leukocyte adhesion deficiency type 1. New infection in chronic granulomatous disease. Medicine (Baltimore)
Engl J Med 2017;376:1141–6. 1998;77:345–54.
19. Etzioni A, Gershoni-Baruch R, Pollack S, et al. Leukocyte adhesion 35. Vinh DC, Shea YR, Jones PA, et al. Chronic invasive aspergillosis caused
deficiency type II: long-term follow-up. J Allergy Clin Immunol by Aspergillus viridinutans. Emerg Infect Dis 2009;15:1292–4.
1998;102:323–4. 36. Siddiqui S, Anderson VL, Hilligoss DM, et al. Fulminant mulch
20. Alon R, Etzioni A. LAD-III, a novel group of leukocyte integrin activation pneumonitis: an emergency presentation of chronic granulomatous
deficiencies. Trends Immunol 2003;24:561–6. disease. Clin Infect Dis 2007;45:673–81.
21. Malinin NL, Zhang L, Choi J, et al. A point mutation in KINDLIN3 37. Greenberg DE, Shoffner AR, Zelazny AM, et al. Recurrent Granulibacter
ablates activation of three integrin subfamilies in humans. Nat Med bethesdensis infections and chronic granulomatous disease. Emerg Infect
2009;15:313–18. Dis 2010;16:1341–8.
22. Svensson L, Howarth K, McDowall A, et al. Leukocyte adhesion 38. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal
deficiency-III is caused by mutations in KINDLIN3 affecting integrin involvement in chronic granulomatous disease. Pediatrics 2004;114:462–8.
activation. Nat Med 2009;15:306–12. 39. De Ravin SS, Naumann N, Cowen EW, et al. Chronic granulomatous
23. Marciano BE, Spalding C, Fitzgerald A, et al. Common severe infections disease as a risk factor for autoimmune disease. J Allergy Clin Immunol
in chronic granulomatous disease. Clin Infect Dis 2015;60:1176–83. 2008;122:1097–103.
24. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 40. Güngör T, Teira P, Slatter M, et al. Reduced-intensity conditioning and
2005;23:197–223. HLA-matched haemopoietic stem-cell transplantation in patients with
25. Papayannopoulos V, Zychlinsky A. NETs: a new strategy for using old chronic granulomatous disease: a prospective multicentre study. Lancet
weapons. Trends Immunol 2009;30:513–21. 2014;383:436–48.
26. Roos D, Kuhns DB, Maddalena A, et al. Hematologically important 41. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med
mutations: X-linked chronic granulomatous disease (third update). Blood 1998;76:676–81.
Cells Mol Dis 2010;45:246–65. 42. Gombart AF, Koeffler HP. Neutrophil specific granule deficiency and
27. Royer-Pokora B, Kunkel LM, Monaco AP, et al. Cloning the gene for an mutations in the gene encoding transcription factor C/EBP(epsilon).
inherited human disorder–chronic granulomatous disease—on the basis Curr Opin Hematol 2002;9:36–42.
of its chromosomal location. Nature 1986;322:32–8. 43. Kaplan J, De Domenico I, Ward DM. Chediak–Higashi syndrome. Curr
28. Deardorff MA, Gaddipati H, Kaplan P, et al. Complex management of a Opin Hematol 2008;15:22–9.
patient with a contiguous Xp11.4 gene deletion involving ornithine 44. Freeman AF, Holland SM. Clinical manifestations, etiology, and
transcarbamylase: a role for detailed molecular analysis in complex pathogenesis of the hyper-IgE syndromes. Pediatr Res 2009;65:32R–37R.
presentations of classical diseases. Mol Genet Metab 2008;94:498–502. 45. Milner JD, Sandler NG, Douek DC. Th17 cells, Job’s syndrome and HIV:
29. Roos D, Kuhns DB, Maddalena A, et al. Hematologically important opportunities for bacterial and fungal infections. Curr Opin HIV AIDS
mutations: the autosomal recessive forms of chronic granulomatous 2010;5:179–83.
disease (second update). Blood Cells Mol Dis 2010;44:291–9. 46. Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency
30. Matute JD, Arias AA, Wright NA, et al. A new genetic subgroup of associated with DOCK8 mutations. N Engl J Med 2009;361:2046–55.
chronic granulomatous disease with autosomal recessive mutations in 47. Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean
p40 phox and selective defects in neutrophil NADPH oxidase activity. disorder of hematopoiesis, lymphatics, and immunity. Blood
Blood 2009;114:3309–15. 2014;123:809–21.
31. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and 48. Elloumi HZ, Holland SM. Diagnostic assays for chronic granulomatous
survival in chronic granulomatous disease. N Engl J Med disease and other neutrophil disorders. Methods Mol Biol
2010;363:2600–10. 2014;1124:517–35.
32. Leiding JW, Freeman AF, Marciano BE, et al. Corticosteroid therapy for
liver abscess in chronic granulomatous disease. Clin Infect Dis
2012;54:694–700.